ClinicalTrials.gov
public full text
Public Domain
Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies
This study is designed to assess the effect of a new PPARgamma modulator on the expression and activity of the lactase enzyme in human intestinal epithelial cells. Based on their previous experimental results, the investigators hypothesized that modulating intestinal PPARgamma activity is a new pharmacological mechanism allowing the control of lactase expression and activity in the gut
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Research progress on protein lactylation in female reproductive disease: molecular mechanisms, functions, and therapeutic implications.#1080565
- The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism#1045225
- Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer#803561
- Pharmacological advances in#389554
- Effect of Oral NAD+ Precursors Administration on Blood NAD+ Concentration in Healthy Adults#1125046
Record · ID 887666
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive